Columbus, OH, United States of America

Waldemar A Priebe


Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 38(Granted Patents)


Location History:

  • Plain City, OH (US) (1985)
  • Columbus, OH (US) (1984 - 1989)

Company Filing History:


Years Active: 1984-1989

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Waldemar A. Priebe: Innovator in Anti-Cancer Antibiotics

Introduction

Waldemar A. Priebe is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer antibiotics. With a total of 7 patents to his name, Priebe's work has had a profound impact on cancer treatment.

Latest Patents

One of Priebe's latest patents includes the invention of 14-Acyloxy-2'-halo-anthracycline anti-cancer antibiotics. This patent discloses compounds of the formula (I) and pharmaceutical preparations containing the same. The compounds are characterized by specific chemical structures where R.sup.1 is --OOCR.sup.3 or --OOC(CH.sub.2).sub.n COOR.sup.4, and R.sup.2 can be hydrogen, hydroxy, or methoxy. The invention highlights the potential of these compounds in inhibiting malignant diseases, showcasing their importance in cancer therapy.

Career Highlights

Throughout his career, Waldemar A. Priebe has worked with esteemed institutions such as The Ohio State University and the United States of America as represented by the Department of Health. His research and innovations have contributed to advancements in medical science, particularly in oncology.

Collaborations

Priebe has collaborated with notable colleagues, including Derek Horton and John S. Swenton. These partnerships have fostered a collaborative environment that has led to significant breakthroughs in his field.

Conclusion

Waldemar A. Priebe's contributions to the development of anti-cancer antibiotics exemplify his dedication to improving healthcare. His innovative work continues to influence the fight against cancer, making him a prominent figure in pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…